Access to Medicines

KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) roadmap

KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) road map 24 February 2021 Whilst calls for better coordination in the EU pandemic response are welcome, HERA must put the global right to health, rather than regional biosecurity concerns, at its heart. Rapid operationalisation, as demanded by global public health needs, …

KEI Europe comments on the European Health Emergency Preparedness and Response Authority (HERA) roadmap Read More »

The European Commission action plan on intellectual property – Of COVID-19, TRIPS, EU BARDA, march-in rights, patent pools, and compulsory licensing

Update: On Wednesday, 25 November 2020, the European Commission published its IP action plan:  Making the most of the EU’s innovative potential – An intellectual property action plan to support the EU’s recovery and resilience. KEI Europe’s President, Dr. Ellen ‘t Hoen provided the following reaction to the European Union’s action plan on intellectual property. …

The European Commission action plan on intellectual property – Of COVID-19, TRIPS, EU BARDA, march-in rights, patent pools, and compulsory licensing Read More »

KEI Europe comments on the European Commission’s roadmap for an Intellectual Property Action Plan

14 August 2020 Compulsory licensing in the Unitary Patent System.  There should be a provision for a unitary compulsory license in the unitary patent system, that is without prejudice to national compulsory licenses on the unitary patent right.   Non patent market exclusivities.  Sui generis exclusive rights regimes, such as but not limited to regulatory test …

KEI Europe comments on the European Commission’s roadmap for an Intellectual Property Action Plan Read More »

2020: USTR takes aim at Europe over pharmaceutical pricing and reimbursement policies

On 31 March 2020, the Office of the United States Trade Representative (USTR) published its 2020 National Trade Estimates Report on Foreign Trade Barriers (NTE). As USTR notes, in “accordance with section 181 of the Trade Act of 1974, as amended by section 303 of the Trade and Tariff Act of 1984 and amended by …

2020: USTR takes aim at Europe over pharmaceutical pricing and reimbursement policies Read More »

January 2020: European Commission publishes its Report on the protection and enforcement of intellectual property rights in third countries

On 8 January 2020 the European Commission published a “Report on the protection and enforcement of intellectual property rights in third countries.” The objective of this report is to “identify third countries in which the state of IPR protection and enforcement (both online and offline) gives rise to the greatest level of concern” (European Commission, …

January 2020: European Commission publishes its Report on the protection and enforcement of intellectual property rights in third countries Read More »

Letter to Italian Minister of Health in support of Dr Luca Li Bassi

On Thursday, 7 November 2019, 21 civil society organizations and 24 individuals including public health experts, and legal analysts sent a letter to Italy’s new Minister of Health, Roberto Speranza expressing support for Dr Luca Li Bassi, the current Director General of Agenzia Italiana del Farmaco (AIFA). The pdf version of the letter can be …

Letter to Italian Minister of Health in support of Dr Luca Li Bassi Read More »

16 Civil society groups write open letter to WHO Director-General Dr Tedros: Roadmap on Access to Medicines and Vaccines 2019-2023

UPDATE: On Wednesday, 15 August 2018, WHO Director-General, Dr Tedros Adhanom Ghebreyesus provided a response to the open letter on the Roadmap on Access to Medicines and Vaccines 2019-2023. The Director-General’s response can be found here: WHO DG letter to KEI 15 August 2018 Access roadmap On Friday, 3 August 2018, 16 groups sent an …

16 Civil society groups write open letter to WHO Director-General Dr Tedros: Roadmap on Access to Medicines and Vaccines 2019-2023 Read More »

Civil Society Asks Upcoming Austrian EU Presidency To Defend Access To Medicines

On 27 June 2018, a small group of activists and public health campaigners organized a demonstration in front of Austria’s Health Ministry. Banners displayed the following messages: “Austrian Presidency of the EU: put patients before profits”, “Pharma 3 – Patients 0”, and “Pharma score goals with high prices”. KEI Europe, along with 11 other groups …

Civil Society Asks Upcoming Austrian EU Presidency To Defend Access To Medicines Read More »

Commissioner Malmström’s response to Civil Society concerns over the Third Country Report on the Protection of IPRs

On 16 April 2018, KEI Europe and 32 groups wrote a letter to the European Commission’s Trade Commissioner, Cecilia Malmström, expressing concerns over the Commission’s plans to create an EU Watch List. In the letter, we noted that although the European Union has publicly reiterated its commitment to support the right of third countries to …

Commissioner Malmström’s response to Civil Society concerns over the Third Country Report on the Protection of IPRs Read More »

Thirty-three civil society groups write to Commissioner Malmström expressing concerns over the European Commission’s plans to create an EU Watch List

On 16 April 2018, KEI Europe and 32 groups wrote a letter to the European Commission’s Trade Commissioner, Cecilia Malmström, expressing concerns over the Commission’s plans to create an EU Watch List. The letter states that “despite the European Union’s public pledge of support for third countries’ right to use the flexibilities of the TRIPS …

Thirty-three civil society groups write to Commissioner Malmström expressing concerns over the European Commission’s plans to create an EU Watch List Read More »